2016 The efficacy of platelet-rich plasma for the treatment of erectile dysfunction: initial outcomes
Joseph J. Banno, MD1, Tyson Kinnick, PA1, Lisbeth Roy, DO2, Paul P. Perito, MD3, Gabriele Antonini, MD4, Daniella Banno1
1: Midwest Urological Group, Peoria, IL; 2: Doctors Studio, Boca Raton, FL; 3: Perito Urology, Miami, FL; 4: Antonini Urology, Roma, Italy
2016 Research Study Comparison of EmCyte GS30-PurePRP® II, EmCyte GS60-PurePRP® II, Arteriocyte MAGELLAN, Stryker REGENKIT®THT, and ECLIPSE PRP
Principle Investigator
Robert Mandle, PhD
Biosciences Research Associates Cambridge, MA
Prepared for: Patrick Pennie Chairman & CEO EmCyte Corporation®
2015 Bone marrow aspirate concentrates produced with the EmCyte GSBMA-544E system and the Harvest/Terumo BMAC2 system
Prepared for: Patrick Pennie
Chairman & CEO EmCyte Corporation
Sample analysis by: Biosciences Research Associates Cambridge, MA
2015 Research Study Comparisons of and EmCyte PurePRP® II 2015, Harvest/Terumo APC60,/Clear PRP, and Arthrex Angel PRP Products
Principle Investigator
Robert Mandie, PhD
Biosciences Research Associates Cambridge, MA
Prepared for: Patrick Pennie, Chairman & CEO EmCyte Corporation
2014 A Pilot Study of the Effect of Localized Injections of Autologous Platelet Rich Plasma (PRP) for the Treatment of Female Sexual Dysfunction
Charles Runels*, Hugh Melnick, Ernest Debourbon and Lisbeth Roy
Medical School, Birmingham, Alabama, USA
